GlassScriptPhysician profile
Douglas R Bree
NPI 1568666485
$32,723.16
in general payments reported to CMS, 2019-2025
58 companies · $2,299 in 2025
The $2,299 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $1,667 · 2021: $1,991 · 2022: $4,747 · 2023: $3,170 · 2024: $2,782 · 2025: $2,299.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,139 · Education: $99.99 · Entertainment: $11.96.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,138.93 |
| Education | $99.99 |
| Entertainment | $11.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $16,711.99 | 2019-2025 | Cardiomems, Aveir, Jot Dx |
| Abiomed | $2,800.14 | 2019-2025 | Impella |
| Boston Scientific Corporation | $1,340.08 | 2020-2025 | Watchman Access System, Bodyguardian, Watchman Flx |
| Cvrx, INC. | $1,106.09 | 2022-2025 | Barostim Neo System |
| Atricure, INC. | $1,102.50 | 2021-2023 | |
| Amgen INC. | $902.91 | 2019-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $809.92 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $685.71 | 2021-2025 | Verquvo, Lagevrio |
| E.R. Squibb & Sons, L.L.C. | $471.88 | 2019-2025 | Eliquis, Camzyos |
| Actelion Pharmaceuticals US, INC. | $414.45 | 2020-2025 | Opsumit, Uptravi |
| Biotronik INC. | $378.27 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $364.80 | 2019-2023 | Xarelto |
| Biosense Webster, INC. | $348.04 | 2022-2024 | Carto 3 |
| Heartflow, INC. | $334.15 | 2019-2024 | Ffrct |
| Baxter Healthcare | $306.91 | 2023-2025 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
Show all 58 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $299.80 | 2021-2025 | Jardiance |
| Esperion Therapeutics, INC. | $276.05 | 2021-2025 | Nexletol |
| Pfizer INC. | $274.03 | 2019-2025 | |
| Tactile Systems Technology INC | $267.41 | 2022-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Cordis US Corp. | $261.78 | 2025 | Selution Slr Ptca |
| Amarin Pharma, INC. | $229.72 | 2019-2022 | |
| Medtronic Vascular, INC. | $227.14 | 2019-2020 | |
| Impulse Dynamics (USA) INC. | $225.68 | 2022-2023 | Optimizer |
| Novo Nordisk INC | $193.66 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $193.63 | 2019-2025 | Lifevest |
| Irhythm Technologies, INC. | $183.14 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Astrazeneca Pharmaceuticals LP | $177.58 | 2019-2025 | Farxiga, Wainua |
| Bard Peripheral Vascular, INC. | $174.00 | 2019-2020 | |
| Vital Connect, INC | $158.75 | 2022 | |
| Sanofi-Aventis U.S. LLC | $148.30 | 2019-2022 | |
| Medtronic, INC. | $136.65 | 2022-2024 | Onyx Frontier, Linq II |
| Kestra Medical Technology Services, INC. | $112.04 | 2025 | Assure Wcd |
| Alnylam Pharmaceuticals INC. | $105.11 | 2022-2025 | Amvuttra |
| Cardiofocus, INC. | $97.89 | 2020 | |
| Cook Medical LLC | $85.72 | 2023-2025 | Zilver Ptx, Advance, Cook Celect |
| Arbor Pharmaceuticals, INC. | $73.03 | 2019-2021 | |
| Altathera Pharmaceuticals LLC | $72.54 | 2023-2024 | Sotalol Hydrochloride |
| Lexicon Pharmaceuticals, INC. | $66.11 | 2023-2024 | Inpefa |
| Cardiovascular Systems INC. | $56.77 | 2019 | |
| Inari Medical, INC. | $52.63 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Ge Healthcare | $49.04 | 2019-2024 | |
| Kowa Pharmaceuticals America, INC. | $47.35 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $45.51 | 2019 | |
| Kiniksa Pharmaceuticals, LTD. | $37.71 | 2022-2023 | Arcalyst |
| Chiesi USA, INC. | $36.97 | 2019-2021 | |
| Cagent Vascular INC | $35.54 | 2025 | Serrantor |
| Bayer Healthcare Pharmaceuticals INC. | $35.17 | 2025 | |
| Azurity Pharmaceuticals, INC. | $34.98 | 2024 | Edarbi |
| Bardy Diagnostics, INC. | $25.00 | 2019-2020 | |
| Althera Pharmaceuticals LLC | $21.96 | 2021 | |
| Scpharmaceuticals INC. | $21.65 | 2024 | |
| Lundbeck LLC | $18.68 | 2019 | |
| Angiodynamics, INC. | $18.62 | 2020 | |
| Preventice Services, LLC | $16.46 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $16.29 | 2024 | Arcalyst |
| Dilon Technologies, INC. | $12.82 | 2022 | |
| Argentum Medical | $11.96 | 2025 | |
| Itamar Medical INC | $10.45 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Bree listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.